Reevaluating diabetes and COVID-19 outcomes using national-level data.

Area of Science:

• Public Health
• Epidemiology
• Chronic Disease Management

Background:

• Diabetes is a prevalent chronic condition in the US adult population.
• Understanding the impact of diabetes on COVID-19 outcomes is crucial for public health.
• Previous studies, often on hospitalized patients, suggested higher risks for individuals with diabetes.

Purpose of the Study:

• To evaluate the association between prevalent diabetes and COVID-19 testing uptake.
• To assess the relationship between diabetes and COVID-19 test positivity rates.
• To examine the link between diabetes and severe COVID-19 symptom severity.

Main Methods:

• Utilized data from the 2020-2021 National Health Interview Survey (NHIS).
• Defined COVID-19 outcomes including test uptake, positivity, diagnosis, and severe symptoms.
• Employed multivariate adjusted logistic and ordered logistic regression models to analyze associations.

Main Results:

• Overall COVID-19 test uptake was 50.7% and test positivity was 9.4%.
• No statistically significant differences in test uptake or positivity were observed between individuals with and without diabetes.
• Individuals with diabetes showed a higher likelihood of severe COVID-19 symptoms, though adjusted models found no significant overall associations with diagnosed diabetes.

Conclusions:

• Findings differ from previous research on hospitalized populations, highlighting potential data source influences.
• This study suggests that diabetes status may not significantly affect COVID-19 testing behaviors or positivity rates in the general US adult population.
• Researchers and policymakers should critically assess data source properties and their implications for public health recommendations, especially during pandemics.